Tag: Immune Disorders
Rituximab, Mycophenolate Mofetil Compared for Pemphigus Vulgaris
More patients receiving rituximab versus mycophenolate mofetil had sustained complete remission at week 52, fewer had disease flares
Gene Therapy Promising for SCID Due to ADA Deficiency
High overall, event-free survival seen at 24 and 36 months for severe combined immunodeficiency due to ADA deficiency
Incidence of Scleritis Down in the United Kingdom
Patients with scleritis have increased risk for prior diagnosis of infectious/immune-mediated inflammatory disease
ICI Need Not Be Withheld in Those With Autoimmune Disease
Objective response rates to anti-CTL4, anti-PD-1, combination similar for advanced melanoma patients with, without AID
COVID-19 Outcomes No Worse for Patients on Immunosuppressive Meds
Findings for ventilator use, length of stay, in-hospital mortality similar for those with, without chronic use of immunosuppressant agents
Atopic Dermatitis Tied to Autoimmune Diseases
Findings strongest for autoimmune diseases involving the skin, the gastrointestinal tract, or connective tissue
Deaths Up During Pandemic for Those With Rare Autoimmune Disorders
Individuals with rare autoimmune rheumatic diseases have prominently increased risk for death versus general population
